Applications of Human-Induced Pluripotent Stem Cells in the Investigation of Inherited Cardiomyopathy.

Qian Zhao,Huanhuan Cai,Yongkun Zhan,Bin Li,Shengshou Hu,Ning Sun
DOI: https://doi.org/10.1016/j.ijcard.2014.08.135
IF: 4.039
2014-01-01
International Journal of Cardiology
Abstract:Cardiomyopathies are a broad range of diseases of the myocardium with associated cardiac dysfunctions and are mainly classified as hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D), restricted cardiomyopathy (RCM) and left ventricular noncompaction cardiomyopathy (LVNC). Cardiomyopathies have a strong genetic component with up to over 40 genes now implicated in inherited cardiomyopathy. Thanks to the development of sequencing technologies, more and more genes and mutations are identified in unexplained cardiomyopathies. However, there remains limited information on the underlying disease mechanisms as well as how these mutations are linked to the disease phenotypes. Although genetic mouse models have contributed to our understanding of the diseases, mouse models have their own limitations in recapitulating human diseases, as the electrical properties, ion channel contributions and cardiac development of mouse CMs are all different from those of humans. On the other hand, cardiac tissues from cardiomyopathy patients are difficult to obtain and to culture. This added great limits on the research of human inherited cardiomyopathy.
What problem does this paper attempt to address?